Esmolol is a cardioselective beta-1 adrenergic receptor blocker, clinically indicated for the management of supraventricular tachycardia, atrial fibrillation, and perioperative hypertension. This category… Read more











































Esmolol is a cardioselective beta-1 adrenergic receptor blocker, clinically indicated for the management of supraventricular tachycardia, atrial fibrillation, and perioperative hypertension. This category provides comprehensive reference standards for the Esmolol active pharmaceutical ingredient, alongside a diverse range of pharmacopeial and non-pharmacopeial impurities and stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for critical analytical tasks, including impurity profiling to monitor degradation products—such as those resulting from hydrolysis or oxidation—and method validation. Stable isotope labelled standards are specifically employed to ensure high precision in quantification during complex analytical testing and routine quality control protocols. These standards remain essential for verifying the safety and efficacy of the drug throughout its manufacturing and stability testing cycles, ensuring compliance with rigorous regulatory requirements for pharmaceutical product quality.